Methods of treating TTR amyloidosis using AG10
US11058668B2 · kind B2 · utility
4Cited by
49References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Mar 22, 2019 |
| Grant date | Jul 13, 2021 |
| Priority date | — |
| Expiry date | Mar 22, 2039 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/02
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Described herein are methods for treating transthyretin (TTR) amyloidosis in a subject. The methods include specific dosing regimens that have great efficacy in treating the subjects and that are well tolerated in subjects.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.